Literature DB >> 22868236

Good penetration of moxifloxacin into human abscesses.

Robert Sauermann1, Rudolf Karch, Maria C Kjellsson, Thomas Feurstein, Andreas Püspök, Herbert Langenberger, Michaela Böhmdorfer, Walter Jäger, Markus Zeitlinger.   

Abstract

Abscesses are often treated with antibiotics in addition to incision or when incision is unfeasible, but accurate information about antibiotic abscess penetration in humans is missing. This study aimed at evaluating the penetration of moxifloxacin into human abscesses. After administration of a single dose of 400 mg moxifloxacin, drug concentrations were measured in 10 differently located abscesses at incision, and in plasma over 8 h. At incision performed 0.9-4.8 h after administration, moxifloxacin concentrations in abscesses ranged from ≤0.01 to 9.2 mg/l (1.9 ± 3.4 mg/l), indicating pronounced drug accumulation in some abscesses. The degree of abscess penetration could not be explained by covariates like the ratio of surface area to volume or pH of abscesses, or by moxifloxacin plasma concentrations. Concluding, moxifloxacin was detectable in most abscesses and may be a useful antibiotic for this indication. However, antibiotic abscess penetration was highly variable and unpredictable, suggesting surgical abscess incision whenever possible.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868236     DOI: 10.1159/000341550

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  Sequential Intravenous-Oral Therapy for Pediatric Streptococcus anginosus Intracranial Infections.

Authors:  Daniel S Dodson; Heather R Heizer; James T Gaensbauer
Journal:  Open Forum Infect Dis       Date:  2022-01-06       Impact factor: 3.835

2.  Lemierre syndrome caused by Klebsiella pneumoniae complicated by epidural abscess - Case report.

Authors:  Peter Sabaka; Mária Kachlíková; Matej Bendžala; Helena Káčerová
Journal:  IDCases       Date:  2019-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.